Accessibility Menu
Lifeward Stock Quote

Lifeward (NASDAQ: LFWD)

$0.55
(5.3%)
+0.03
Price as of November 14, 2025, 11:45 a.m. ET

KEY DATA POINTS

Current Price
$0.55
Daily Change
(5.3%) +$0.03
Day's Range
$0.52 - $0.58
Previous Close
$0.52
Open
$0.52
Beta
0.98
Volume
263,224
Average Volume
339,859
Market Cap
8.2M
Market Cap / Employee
$0.52M
52wk Range
$0.50 - $4.00
Revenue
-
Gross Margin
0.34%
Dividend Yield
N/A
EPS
-$3.13
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Lifeward Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
LFWD-73.97%-93.42%-41.95%-100%
S&P+12.57%+87.93%+13.44%+239%

Lifeward Company Info

ReWalk Robotics Ltd. Is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Yokneam Ilit, Israel.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$5.72M-14.7%
Gross Profit$2.51M11.3%
Gross Margin43.87%10.2%
Market Cap$7.48M-78.3%
Market Cap / Employee$0.09M0.0%
Employees80-25.9%
Net Income-$6.56M-52.5%
EBITDA-$3.69M-5.8%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$5.35M-64.6%
Accounts Receivable$5.86M11.3%
Inventory7.66.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$0.08M-35.8%
Short Term Debt$0.30M-74.6%

Ratios

Q2 2025YOY Change
Return On Assets-76.54%-35.9%
Return On Invested Capital-60.05%-7.8%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$3.94M29.9%
Operating Free Cash Flow-$3.94M29.9%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book0.770.450.790.37-56.27%
Price to Sales1.140.590.700.30-80.02%
Price to Tangible Book Value1.540.931.320.63-61.08%
Enterprise Value to EBITDA-8.55-2.05-2.63-0.61-89.66%
Return on Equity-45.1%-88.6%-93.1%-114.9%131.40%
Total Debt$0.98M$0.88M$0.62M$0.38M-70.93%

No results found

No podcast episodes available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.